4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001834418-26-000002
Options or other derivatives
- Chief Technology Officer acquired 539,265 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lecault Veronique Chief Technology Officer | 2026-01-01 | Grant or award · Share option (right to buy) | +539,265 | 5,201,069 | D | ||
Loading xslF345X05/wk-form4_1767632934.xml…